These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 11087979)
1. Urinary excretion of 4-hydroxyamphetamine and amphetamine in male and female Sprague-Dawley and Dark Agouti rats following multiple doses of amphetamine. Law MY; Moody DE Toxicol Lett; 2000 Nov; 117(3):139-44. PubMed ID: 11087979 [TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of amphetamine and 4'-hydroxyamphetamine by Sprague Dawley and dark Agouti rats. Law MY; Moody DE Life Sci; 1994; 54(15):1073-9. PubMed ID: 8152328 [TBL] [Abstract][Full Text] [Related]
3. Selective involvement of cytochrome P450 2D subfamily in in vivo 4-hydroxylation of amphetamine in rat. Law MY; Slawson MH; Moody DE Drug Metab Dispos; 2000 Mar; 28(3):348-53. PubMed ID: 10681381 [TBL] [Abstract][Full Text] [Related]
4. Quinidine inhibits in vivo metabolism of amphetamine in rats: impact upon correlation between GC/MS and immunoassay findings in rat urine. Moody DE; Ruangyuttikarn W; Law MY J Anal Toxicol; 1990; 14(5):311-7. PubMed ID: 2263067 [TBL] [Abstract][Full Text] [Related]
5. Species variation with respect to the metabolism and excretion of d-amphetamine and d,l-N-hydroxyamphetamine succinate. Danielson TJ; Davis BA; Boulton AA Can J Physiol Pharmacol; 1977 Jun; 55(3):439-43. PubMed ID: 884602 [TBL] [Abstract][Full Text] [Related]
6. Determination of amphetamine and its metabolite p-hydroxyamphetamine in rat urine by reversed-phase high-performance liquid chromatography after dabsyl derivatization. Soares ME; Carvalho F; Bastos ML Biomed Chromatogr; 2001 Nov; 15(7):452-6. PubMed ID: 11746241 [TBL] [Abstract][Full Text] [Related]
7. Urinary output changes in racemic ethylamphetamine and optical activity discrimination in rat urine by HPLC analysis. Matsushima K; Nagai T; Kanaya H; Kato Y; Takahashi M; Kamiyama S Nihon Hoigaku Zasshi; 1998 Feb; 52(1):19-26. PubMed ID: 9591399 [TBL] [Abstract][Full Text] [Related]
8. Simultaneous HPLC analysis of optical isomers of methamphetamine and its metabolites, and stereoselective metabolism of racemic methamphetamine in rat urine. Nagai T; Kamiyama S J Anal Toxicol; 1991; 15(6):299-304. PubMed ID: 1685757 [TBL] [Abstract][Full Text] [Related]
9. Urinary metabolites of p-hydroxyamphetamine in man, rat and guinea-pig. Sever PS; Dring LG; Williams RT Xenobiotica; 1976 Jun; 6(6):345-53. PubMed ID: 969562 [TBL] [Abstract][Full Text] [Related]
10. Identification of new urinary metabolites of famprofazone in humans. Shin HS; Park BB; Choi SN; Oh JJ; Hong CP; Ryu H J Anal Toxicol; 1998; 22(1):55-60. PubMed ID: 9491970 [TBL] [Abstract][Full Text] [Related]
11. Blood pressure and heart rate response evoked by p-hydroxyamphetamine and by p-hydroxynorephedrine II. A quantitative assessment of the role of amphetamine metabolites in acute responses evoked by d-amphetamine. Simpson LL J Pharmacol Exp Ther; 1980 Jun; 213(3):504-8. PubMed ID: 7205614 [TBL] [Abstract][Full Text] [Related]
12. d-Amphetamine interaction with glutathione in freshly isolated rat hepatocytes. Carvalho F; Remião F; Amado F; Domingues P; Correia AJ; Bastos ML Chem Res Toxicol; 1996 Sep; 9(6):1031-6. PubMed ID: 8870992 [TBL] [Abstract][Full Text] [Related]
13. Strain differences in diazepam metabolism at its three metabolic sites in sprague-dawley, brown norway, dark agouti, and wistar strain rats. Saito K; Sakai N; Kim HS; Ishizuka M; Kazusaka A; Fujita S Drug Metab Dispos; 2004 Sep; 32(9):959-65. PubMed ID: 15319337 [TBL] [Abstract][Full Text] [Related]
14. Disposition kinetics of d- and l-amphetamine following intravenous administration of racemic amphetamine to rats. Hutchaleelaha A; Sukbuntherng J; Chow HH; Mayersohn M Drug Metab Dispos; 1994; 22(3):406-11. PubMed ID: 8070317 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of methamphetamine and its metabolites in monkey urine by gas chromatography/mass spectrometry with selected ion monitoring. Yamamoto T; Takano R; Egashira T; Yamanaka Y; Terada M J Anal Toxicol; 1989; 13(2):117-9. PubMed ID: 2733390 [TBL] [Abstract][Full Text] [Related]
16. The metabolic fate of amphetamine in man and other species. Dring LG; Smith RL; Williams RT Biochem J; 1970 Feb; 116(3):425-35. PubMed ID: 4985156 [TBL] [Abstract][Full Text] [Related]
17. Distribution and occurrence of amphetamine and p-hydroxyamphetamine in tissues of the rat after injection of d-amphetamine sulfate. Danielson TJ; Boulton AA Eur J Pharmacol; 1976 Jun; 37(2):257-64. PubMed ID: 954809 [TBL] [Abstract][Full Text] [Related]
18. Role of training conditions in discrimination of central nervous system stimulants by rats. Stolerman IP; D'Mello GD Psychopharmacology (Berl); 1981; 73(3):295-303. PubMed ID: 6113619 [TBL] [Abstract][Full Text] [Related]
20. Interindividual and interspecies variation in the metabolism of the hallucinogen 4-methoxyamphetamine. Kitchen I; Tremblay J; André J; Dring LG; Idle JR; Smith RL; Williams RT Xenobiotica; 1979 Jul; 9(7):397-404. PubMed ID: 582863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]